Aβ Imaging: Feasible, Pertinent, and Vital to Progress in Alzheimer’s Disease
View/ Open
Author
Villemagne, Victor L.
Klunk, William E.
Mathis, Chester A.
Rowe, Christopher C.
Ikonomovic, Milos D.
Ishii, Kenji
Jack, Clifford R.
Jagust, William J.
Koeppe, Robert A.
Lowe, Val J.
Masters, Colin L.
Montine, Thomas J.
Morris, John C.
Nordberg, Agneta
Petersen, Ronald C.
Reiman, Eric M.
Van Laere, Koen
Drzezga, Alexander
Brooks, David J.
Weiner, Michael W.
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1007/s00259-011-2045-0Metadata
Show full item recordCitation
Villemagne, Victor L., William E. Klunk, Chester A. Mathis, Christopher C. Rowe, David J. Brooks, Bradley T. Hyman, Milos D. Ikonomovic, et al. 2012. Aβ Imaging: Feasible, pertinent, and vital to progress in Alzheimer’s disease. European Journal of Nuclear Medicine and Molecular Imaging 39(2): 209-219.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261395/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:9361509
Collections
- HMS Scholarly Articles [17922]
Contact administrator regarding this item (to report mistakes or request changes)